Abstract 1912: Study on the role of targeting ERBB and its potential resistance mechanism in biliary tract cancer

• Published in: Cancer research (Chicago, Ill.) Vol. 80; no. 16_Supplement; p. 1912
• Main Authors: Feng, Feiling, Cheng, Qingbao, Zhang, Dadong, Liu, Chen, Xu, Xiaoya, Li, Bin, Wang, Huizhen, Yu, Yong, Wu, Xiaobing, Zhou, Jun, Chu, Kaijian, Xie, Zhenghua, Gao, Qingxiang, Xiong, Lei, Li, Fugen, Yi, Bin, Jiang, Xiaoqing
• Format: Journal Article
• Language: English
• Published: 15.08.2020

Abstract Purpose: Biliary tract cancer (BTC) is a kind of malignant digestive system tumors without a targeted drug approved in the clinic. A high proportion of gene mutations and abnormal expressions of ERBB pathway have been reported in BTC. However, there are few studies on targeting ERBB in BTC....